Press releases
Press releases
Here we list English translations of the Swedish press releases published by Neola Medical AB (publ). For official press releases, please visit our Swedish website.
Neola Medical initiates Human Factors Validation Study in the USA ahead of FDA application for market approval
Press communication Lund, Sweden, February 29 This is a translation of the Swedish press release published 2024-02-29, 07.00 CET Neola Medical AB (publ) will commence a Human Factors Validation Study in March 2024 with Neola®, the company's medical device for...
Neola Medical Q4 report of 2023 – With a strengthened cash position, another show of strength is delivered through patent protection for future profitability drivers
Press communication Lund, Sweden, February 14 This is a translation of the Swedish press release published 2024-02-14, 08.00 CET Neola Medical AB (publ) today publishes the Q4 report of 2023 (in Swedish). The report is available at the company's website and is...
Neola Medical invites to presentation of the Q4-report 2023
Press communication Lund, Sweden, 5 February 2024 This is a translation of the Swedish press release published 2024-02-05 Neola Medical AB (publ) invites to presentation of the Q4-report of 2023, Wednesday the 14th of February 2024 at 11am CET (11.00). The...
CEO Hanna Sjöström is participating in the J.P. Morgan Healthcare Conference in San Francisco for meetings with investors and industry partners
Press communication Lund, Sweden, January 8 2024 This is a translation of the Swedish press release published 2024-01-08 Neola Medical AB (publ) will be present at the investor conference J.P. Morgan Healthcare Conference in San Francisco in January 2024. CEO Hanna...
Neola Medical’s CEO shares more about the latest news in the winter investor letter 2023
Press communication Lund, Sweden, December 19 2023 This is a translation of the Swedish press release published 2023-12-19 Market preparations for the launch in the U.S. continue with the newly established subsidiary, Neola Medical, Inc., in the U.S, new patent for...
Neola Medical carries out a directed share issue of SEK 20 million and thereby secures financing for 2024
NOT FOR PUBLICATION, DISTRIBUTION, OR DISCLOSURE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH ACTION...
Neola Medical has been granted a patent in Europe for the company’s disposables
Press communication Lund, Sweden, December 12 2023 This is a translation of the Swedish press release published 2023-12-12 Neola Medical AB (publ) announced today that the company has been granted a new patent in Europe for a strategically important invention in...
Neola Medical AB starts a subsidiary in the USA
Press communication Lund, Sweden, December 4 2023 This is a translation of the Swedish press release published 2023-12-04 Neola Medical AB (publ) has started a subsidiary in the USA as part of the upcoming launch of Neola® on the American market. The company's...
Neola Medical’s CEO tells more about the latest news in the investor letter for autumn 2023
Press communication Lund, Sweden, November 15 2023 This is a translation of the Swedish press release published 2023-11-15 Market preparations for launch in the U.S. continue with a new exclusive collaboration with Stanford, enhanced protection for Neola® through...
Neola Medical Q3 report 2023 – Doors open in the U.S. with Stanford support and new strong final results from independent clinical trial in newborns
This is a translation of the Swedish press release published 2023-11-09, 07:55 CET New successful results from the completed independent clinical trial in Ireland show that Neola® measures oxygen in the lungs of 100% of the participating 100 newborn babies....
